Bausch Health Companies Inc. (TSX: BHC)
Canada
· Delayed Price · Currency is CAD
12.81
+1.44 (12.66%)
Oct 31, 2024, 4:00 PM EDT
Bausch Health Companies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 9,103 | 8,663 | 8,025 | 8,328 | 7,924 | 8,489 | Upgrade
|
Other Revenue | 99 | 94 | 99 | 106 | 103 | 112 | Upgrade
|
Revenue | 9,202 | 8,757 | 8,124 | 8,434 | 8,027 | 8,601 | Upgrade
|
Revenue Growth (YoY) | 10.20% | 7.79% | -3.68% | 5.07% | -6.67% | 2.64% | Upgrade
|
Cost of Revenue | 2,687 | 2,559 | 2,364 | 2,394 | 2,249 | 2,350 | Upgrade
|
Gross Profit | 6,515 | 6,198 | 5,760 | 6,040 | 5,778 | 6,251 | Upgrade
|
Selling, General & Admin | 3,090 | 2,895 | 2,531 | 2,492 | 2,367 | 2,554 | Upgrade
|
Research & Development | 612 | 604 | 529 | 465 | 452 | 471 | Upgrade
|
Other Operating Expenses | 3 | 1 | 1 | - | 1 | -13 | Upgrade
|
Operating Expenses | 4,784 | 4,577 | 4,276 | 4,332 | 4,465 | 4,909 | Upgrade
|
Operating Income | 1,731 | 1,621 | 1,484 | 1,708 | 1,313 | 1,342 | Upgrade
|
Interest Expense | -1,407 | -1,328 | -1,464 | -1,426 | -1,534 | -1,612 | Upgrade
|
Interest & Investment Income | 30 | 26 | 14 | 7 | 13 | 12 | Upgrade
|
Currency Exchange Gain (Loss) | -47 | -52 | -8 | 7 | -30 | 8 | Upgrade
|
EBT Excluding Unusual Items | 307 | 267 | 26 | 296 | -238 | -250 | Upgrade
|
Merger & Restructuring Charges | -86 | -95 | -68 | -73 | -23 | -44 | Upgrade
|
Impairment of Goodwill | -493 | -493 | -824 | -469 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 9 | 3 | 5 | 2 | 1 | 31 | Upgrade
|
Asset Writedown | -6 | -45 | -10 | -211 | -112 | -66 | Upgrade
|
Legal Settlements | -27 | - | -9 | -356 | -422 | -1,401 | Upgrade
|
Other Unusual Items | -32 | -80 | 752 | -205 | -107 | -62 | Upgrade
|
Pretax Income | -354 | -390 | -129 | -1,024 | -934 | -1,837 | Upgrade
|
Income Tax Expense | 153 | 221 | 83 | -87 | -375 | -54 | Upgrade
|
Earnings From Continuing Operations | -507 | -611 | -212 | -937 | -559 | -1,783 | Upgrade
|
Minority Interest in Earnings | 36 | 19 | -13 | -11 | -1 | -5 | Upgrade
|
Net Income | -471 | -592 | -225 | -948 | -560 | -1,788 | Upgrade
|
Net Income to Common | -471 | -592 | -225 | -948 | -560 | -1,788 | Upgrade
|
Shares Outstanding (Basic) | 367 | 365 | 362 | 359 | 355 | 352 | Upgrade
|
Shares Outstanding (Diluted) | 367 | 365 | 362 | 359 | 355 | 352 | Upgrade
|
Shares Change (YoY) | 0.89% | 0.80% | 0.86% | 1.10% | 0.82% | 0.23% | Upgrade
|
EPS (Basic) | -1.28 | -1.62 | -0.62 | -2.64 | -1.58 | -5.08 | Upgrade
|
EPS (Diluted) | -1.29 | -1.62 | -0.62 | -2.64 | -1.58 | -5.08 | Upgrade
|
Free Cash Flow | 963 | 817 | -946 | 1,157 | 809 | 1,231 | Upgrade
|
Free Cash Flow Per Share | 2.63 | 2.24 | -2.61 | 3.22 | 2.28 | 3.50 | Upgrade
|
Gross Margin | 70.80% | 70.78% | 70.90% | 71.61% | 71.98% | 72.68% | Upgrade
|
Operating Margin | 18.81% | 18.51% | 18.27% | 20.25% | 16.36% | 15.60% | Upgrade
|
Profit Margin | -5.12% | -6.76% | -2.77% | -11.24% | -6.98% | -20.79% | Upgrade
|
Free Cash Flow Margin | 10.47% | 9.33% | -11.64% | 13.72% | 10.08% | 14.31% | Upgrade
|
EBITDA | 2,999 | 2,885 | 2,878 | 3,260 | 3,138 | 3,417 | Upgrade
|
EBITDA Margin | 32.59% | 32.95% | 35.43% | 38.65% | 39.09% | 39.73% | Upgrade
|
D&A For EBITDA | 1,268 | 1,264 | 1,394 | 1,552 | 1,825 | 2,075 | Upgrade
|
EBIT | 1,731 | 1,621 | 1,484 | 1,708 | 1,313 | 1,342 | Upgrade
|
EBIT Margin | 18.81% | 18.51% | 18.27% | 20.25% | 16.36% | 15.60% | Upgrade
|
Revenue as Reported | 9,202 | 8,757 | 8,124 | 8,434 | 8,027 | 8,601 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.